0001104659-20-000872.txt : 20200103
0001104659-20-000872.hdr.sgml : 20200103
20200103161032
ACCESSION NUMBER: 0001104659-20-000872
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200101
FILED AS OF DATE: 20200103
DATE AS OF CHANGE: 20200103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Erlander Mark
CENTRAL INDEX KEY: 0001651537
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35558
FILM NUMBER: 20505379
MAIL ADDRESS:
STREET 1: C/O TROVAGENE, INC.
STREET 2: 11055 FLINTKOTE AVENUE, SUITE A
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Trovagene, Inc.
CENTRAL INDEX KEY: 0001213037
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 272004382
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11055 FLINTKOTE AVENUE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-952-7570
MAIL ADDRESS:
STREET 1: 11055 FLINTKOTE AVENUE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: TrovaGene Inc.
DATE OF NAME CHANGE: 20110830
FORMER COMPANY:
FORMER CONFORMED NAME: XENOMICS INC
DATE OF NAME CHANGE: 20040719
FORMER COMPANY:
FORMER CONFORMED NAME: USED KAR PARTS INC
DATE OF NAME CHANGE: 20030106
4
1
a4.xml
4
X0306
4
2020-01-01
0
0001213037
Trovagene, Inc.
TROV
0001651537
Erlander Mark
C/O TROVAGENE, INC.
11055 FLINTKOTE
SAN DIEGO
CA
92121
0
1
0
0
Chief Scientific Officer
Common Stock
2020-01-01
4
M
0
1250
0
A
6783
D
Common Stock
2020-01-03
4
F
0
552
0
D
6231
D
Restricted Stock Units
2020-01-01
4
M
0
1250
0
D
Common Stock
1250
521
D
Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On July 24, 2018, the reporting person was granted 7,500 restricted stock units, 1,250 of which vested on January 1, 2020. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on July 26, 2018.
The reporting person is reporting the withholding by Trovagene, Inc. of 552 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of the Converted Common Stock to the reporting person on January l, 2020.
Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.
On July 24, 2018, the reporting person was granted 7,500 restricted stock units, 1,250 of which vested on January 1, 2020. The common stock into which such vested restricted stock units converted on January 1, 2020 is reported in Table I on this Form 4.
/s/ Mark Erlander
2020-01-03